Drug Development

Biopharma company Enveric Biosciences (NASDAQ: ENVB) has shared new findings involving the first-ever isolation of a specific enzyme from the cane toad, plus the successful development of a bioproduction platform for the isolation and pharmacological screening of novel molecules belonging to the...

Life sciences biotech Psyence Group Inc. (OTCQB: PSYGF) has closed the second tranche of its previously announced private placement of up to $2.2 million (CA$3 million). The company issued more than 7.7 million common shares at a unit price of $0.09 (CA$0.12) for gross proceeds of $680.458 (CA$930,...